

Philippines Battles 543% Surge in HIV Infections
The Philippines is grappling with a 543% surge in new HIV infections between 2010 and 2023, primarily affecting young men who have sex with men, prompting government initiatives like free testing and treatment at accessible clinics to combat the crisis and destigmatize sexual healthcare.
Philippines Battles 543% Surge in HIV Infections
The Philippines is grappling with a 543% surge in new HIV infections between 2010 and 2023, primarily affecting young men who have sex with men, prompting government initiatives like free testing and treatment at accessible clinics to combat the crisis and destigmatize sexual healthcare.
Progress
40% Bias Score


Philippines HIV Infections Surge Among Youth
The Philippines is experiencing a drastic 543% increase in new HIV infections between 2010 and 2023, with nearly half of 2024 infections affecting 15-24 year olds, mostly men who have sex with men (MSM), highlighting insufficient public awareness and access to prevention and testing.
Philippines HIV Infections Surge Among Youth
The Philippines is experiencing a drastic 543% increase in new HIV infections between 2010 and 2023, with nearly half of 2024 infections affecting 15-24 year olds, mostly men who have sex with men (MSM), highlighting insufficient public awareness and access to prevention and testing.
Progress
32% Bias Score


"Botswana's CAT Epidemic: A Growing Threat to Youth"
"The affordable stimulant drug CAT (methcathinone) is causing a surge in addiction among Botswana's youth, leading to serious health issues and social problems, highlighting the urgent need for comprehensive intervention strategies."
"Botswana's CAT Epidemic: A Growing Threat to Youth"
"The affordable stimulant drug CAT (methcathinone) is causing a surge in addiction among Botswana's youth, leading to serious health issues and social problems, highlighting the urgent need for comprehensive intervention strategies."
Progress
24% Bias Score


China Sets Ambitious HIV/AIDS Prevention Goals for 2030
China's new plan aims to reduce its HIV prevalence rate to below 0.2% by 2030 by tackling high infection rates among men who have sex with men and covert transmission among heterosexual couples, focusing on increased public awareness, improved testing, and treatment access.
China Sets Ambitious HIV/AIDS Prevention Goals for 2030
China's new plan aims to reduce its HIV prevalence rate to below 0.2% by 2030 by tackling high infection rates among men who have sex with men and covert transmission among heterosexual couples, focusing on increased public awareness, improved testing, and treatment access.
Progress
40% Bias Score


Lenacapavir: Six-Monthly HIV Prevention Injection Named "Science" Breakthrough of the Year
"Science" magazine selected Lenacapavir, a six-monthly HIV-prevention injection, as its 2024 Breakthrough of the Year due to its superior efficacy and convenience compared to daily pills, potentially impacting global HIV prevention efforts.
Lenacapavir: Six-Monthly HIV Prevention Injection Named "Science" Breakthrough of the Year
"Science" magazine selected Lenacapavir, a six-monthly HIV-prevention injection, as its 2024 Breakthrough of the Year due to its superior efficacy and convenience compared to daily pills, potentially impacting global HIV prevention efforts.
Progress
36% Bias Score


AIDS Memorial Quilt Displayed at White House for World AIDS Day
President Biden displayed the AIDS Memorial Quilt on the White House lawn for World AIDS Day, honoring the 1.2 million Americans with HIV and the 40 million worldwide; the event highlighted government support for HIV/AIDS prevention and treatment.
AIDS Memorial Quilt Displayed at White House for World AIDS Day
President Biden displayed the AIDS Memorial Quilt on the White House lawn for World AIDS Day, honoring the 1.2 million Americans with HIV and the 40 million worldwide; the event highlighted government support for HIV/AIDS prevention and treatment.
Progress
36% Bias Score

Medical Breakthroughs Offer Hope for AIDS, Schizophrenia, and Alzheimer's
New semi-annual HIV treatment lenacapavir, novel schizophrenia drug 'Copenfi', and Alzheimer's drug Lecanemab offer hope but face cost and accessibility challenges.

Medical Breakthroughs Offer Hope for AIDS, Schizophrenia, and Alzheimer's
New semi-annual HIV treatment lenacapavir, novel schizophrenia drug 'Copenfi', and Alzheimer's drug Lecanemab offer hope but face cost and accessibility challenges.
Progress
40% Bias Score

Global AIDS Initiatives Save Millions, but Child Disparities Persist
Global health programs have drastically reduced AIDS-related deaths from 2.1 million in 2004 to 630,000 today, saving over 65 million lives; however, disparities in child testing and treatment access remain a significant challenge.

Global AIDS Initiatives Save Millions, but Child Disparities Persist
Global health programs have drastically reduced AIDS-related deaths from 2.1 million in 2004 to 630,000 today, saving over 65 million lives; however, disparities in child testing and treatment access remain a significant challenge.
Progress
32% Bias Score

Lenacapavir: Science's 2024 Breakthrough in HIV Prevention
Science magazine named the injectable HIV prevention drug lenacapavir its 2024 breakthrough; 99.9% effective in preventing HIV in clinical trials among men who have sex with men and transgender individuals, offering a six-month dosage alternative to daily oral PrEP, pending FDA (2025) and European a...

Lenacapavir: Science's 2024 Breakthrough in HIV Prevention
Science magazine named the injectable HIV prevention drug lenacapavir its 2024 breakthrough; 99.9% effective in preventing HIV in clinical trials among men who have sex with men and transgender individuals, offering a six-month dosage alternative to daily oral PrEP, pending FDA (2025) and European a...
Progress
32% Bias Score

Lenacapavir: A Breakthrough in HIV Prevention
Two large clinical trials showed lenacapavir, a twice-yearly injection, to be 96–100% effective in preventing HIV, exceeding daily oral PrEP's real-world effectiveness; this breakthrough could significantly curb the global HIV epidemic, though access challenges remain.

Lenacapavir: A Breakthrough in HIV Prevention
Two large clinical trials showed lenacapavir, a twice-yearly injection, to be 96–100% effective in preventing HIV, exceeding daily oral PrEP's real-world effectiveness; this breakthrough could significantly curb the global HIV epidemic, though access challenges remain.
Progress
52% Bias Score

Israel Sees 11% Drop in New HIV/AIDS Cases in 2023
Israel recorded 407 new HIV/AIDS cases in 2023, an 11% decrease from 2022, with a rate of 4.1 per 100,000, lower than Western averages; this may be linked to decreased immigration; updated Health Ministry procedures led to only two perinatal transmissions.

Israel Sees 11% Drop in New HIV/AIDS Cases in 2023
Israel recorded 407 new HIV/AIDS cases in 2023, an 11% decrease from 2022, with a rate of 4.1 per 100,000, lower than Western averages; this may be linked to decreased immigration; updated Health Ministry procedures led to only two perinatal transmissions.
Progress
24% Bias Score

Funding Shortfall Threatens Progress Against HIV/AIDS in Africa
Despite remarkable progress in reducing HIV infections in sub-Saharan Africa (59% reduction in eastern and southern Africa, 46% in west and central Africa since 2001), a funding shortfall of US$8.5 billion (2022) threatens sustainability, as 9.2 million lack treatment and 630,000 died in 2023.

Funding Shortfall Threatens Progress Against HIV/AIDS in Africa
Despite remarkable progress in reducing HIV infections in sub-Saharan Africa (59% reduction in eastern and southern Africa, 46% in west and central Africa since 2001), a funding shortfall of US$8.5 billion (2022) threatens sustainability, as 9.2 million lack treatment and 630,000 died in 2023.
Progress
40% Bias Score